BioSpace News Archive

Career Advice

10 Bad (Yet Surprisingly Common) Workplace Habits to Drop ASAP

Your workplace habits can interfere with your work life and cause professional imbalance. Therefore, you should avoid these habits to boost your productivity.

October 2, 2018
·
4 min read
·
Editorial Staff
Pharm Country

Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire

Immuno-oncology comes pretty close to being a miracle cure for certain types of cancer. But it’s not perfect, and a recently reported isolated case demonstrates that there are risks.

October 2, 2018
·
3 min read
·
Mark Terry
Psychotropic polypharmacy is common in Alzheimer’s disease

Up to half of people with Alzheimer’s disease (AD) use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

October 2, 2018
·
2 min read
Pharm Country

Technology Is Revolutionizing Clinical Trials: Here’s How

Technology has had a massive impact on basically every area of life. One very important part of medical research that technology has been having a noticeable impact on is clinical trials.

October 2, 2018
·
4 min read
·
Sasha Mortimer
Drug Development

Promising Early-Stage Results for Novel Malaria Therapeutics

Two antimalarial strategies have been published from Imperial College London in the past month: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.

October 2, 2018
·
4 min read
·
Chelsea Weidman Burke
Deals

PharmaBlock Acquires a GMP compliant Manufacturing Facility to Support Ongoing Customer Demand

Facility is acquired from Porton Pharma Solutions Ltd., and operated with GMP compliance.

October 2, 2018
·
4 min read
Policy

Ministry of Health & Prevention focuses on intellectual property to combat Counterfeit Medicines and Illicit Drugs to protect citizen’s health

Ministry presents initiatives at 12th International Law Enforcement Intellectual Property Crime Conference

October 2, 2018
·
6 min read
Business

3 Months After Launching a Phase Ib Trial, Janssen Terminates Collaboration Deal with Aduro Biotech

Janssen Biotech, a Johnson & Johnson company, informed Aduro Biotech that it was terminating its research and license deals related to Aduro’s Listeria treatment for cancers.

October 2, 2018
·
2 min read
·
Mark Terry
Business

Momenta Slashes Workforce and Leadership Following Strategic Review

Despite winning regulatory approval for a copycat version of Copaxone earlier this year, Cambridge, Mass.-based Momenta Pharmaceuticals has completed a strategic review that includes slashing its staff by 50 percent as the company focuses its resources on two biosimilar candidates in its pipeline.

October 2, 2018
·
2 min read
·
Alex Keown
Business

Ministry of Health & Prevention partners with Pfizer Gulf to provide free medication to cancer & rheumatoid arthritis patients

One-year scheme under ATAA & TADAMON initiatives for financially challenged patients

October 2, 2018
·
2 min read